EUCTR2019-002959-42-FR进行中（未招募）1 期
Optimization of the use of anti-TNF antibodies in Verneuil's disease: Interest of a systematic initial prescription of methotrexate - ADHAS
Groupement de Coopération Sanitaire Ramsay Générale de Santé pour l’Enseignement et la Recherche0 个研究点目标入组 180 人开始时间: 2019年11月19日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •-Female or male
- •-Age >18 years
- •-Diagnosis of Verneuil's disease: stages of Hurley II and III
- •-No more than 20 abscesses or inflammatory nodules
- •-Written informed consent
- •-Patient affiliated or beneficiary of a social security
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 180
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Age < 18 years
- •-Stage III or IV heart failure
- •-Positive HIV serology
- •-Hepatitis C or B positive serology
- •-Latent tuberculosis (positive quantiferon)
- •-Severe hepatic insufficiency
- •-Previous treatments with adalimumab or infliximab.
- •-Severe progressive hepatic disease
- •-Cancer treatment under 5 years
研究者
相似试验
已完成
不适用
The study of the effectiveness of anti-TNF antibody maintenance treatment combined with elemental diet for Crohn's disease patientss diseaseCrohn's diseaseJPRN-UMIN000007343Tohoku University Graduate School of Medicine (Tohoku University Hospital)90
进行中（未招募）
1 期
To see whether for patients with established rheumatoid arthritis that have already achieved a good response to Tumour Necrosis Factor Inhibitor (TNF inhibitor) treatment, whether the treatment be tapered to a minimum dose without affecting the control of disease activity.EUCTR2010-020738-24-GBKing's College London97
已完成
不适用
Tight control for the anti- TNF alpha antibody- treated CD (Crohn's disease) patients with thiopurine intensification determined by the capsule endoscopic appearances of small intestinal rejoinss diseaseCrohn's diseaseJPRN-UMIN000013078Saitama Medical Center50
招募中
不适用
Impact of anti-tumor necrosis factor antibodies treatment on the semen quality of inflammatory bowel diseases patientsfertilityreproduction10013356NL-OMON33788Erasmus MC, Universitair Medisch Centrum Rotterdam20
进行中（未招募）
不适用
Impact of anti-tumor necrosis factors antibodies treatment on fertility of inflammatory bowel diseases male patientsFertility influenced by antiTNF treatmentMedDRA version: 9.1Level: LLTClassification code 10016469Term: Fertility investigationsEUCTR2008-005619-16-NLErasmus Medical Center